Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Olivier Bohuon takes post at Pierre Fabre

September 6, 2010 Sales and Marketing Pierre Fabre, appointment, sales and marketing

French pharma company Pierre Fabre has officially appointed Olivier Bohuon to take over from Jean-Pierre Garnier as chief executive. Olivier’s …
Appointment
Multaq tablets

Sanofi’s Multaq in pole position for AF market

September 6, 2010 Sales and Marketing Multaq, Sanofi-Aventis, atrial fibrilation

New European Society of Cardiology guidelines on treating atrial fibrillation (AF) include a recommendation for Sanofi-Aventis’ Multaq. The endorsement is …
News

Pradaxa, Xarelto and apixaban vie for attention

September 6, 2010 Research and Development, Sales and Marketing Pradaxa, Xarelto, apixaban, atrial fibrilation

New data has intensified the competition between three rival would-be cardiology blockbusters. Boehringer Ingelheim’s Pradaxa (dabigatran) and Bayer’s Xarelto (rivaroxaban) …
News

Watchdog resignation forced ‘to appease pharma’

September 6, 2010 Sales and Marketing Germany, IQWIG

The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …
News
Roche building

Roche set for jobs cuts from 2011

September 3, 2010 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, job cuts

Roche has confirmed it will take wide-ranging steps to reduce costs, following local reports the Swiss pharma firm was poised …
News

AZ’s Seroquel extends European licence

September 3, 2010 Sales and Marketing AstraZeneca, Seroquel

AstraZeneca’s controversial anti-psychotic drug Seroquel has been given the green light in Europe as an add-on treatment for serious depressive …
News

Merck wins double approval in Europe

September 3, 2010 Sales and Marketing Brinavess, Merck & Co, Syncrest, merck sharp and dohme

European regulators have given the green light for two of Merck & Co’s new drugs, licensing its anti-psychotic treatment Sycrest …
News

Industry supports Australia’s new price deal

September 3, 2010 Sales and Marketing Australia, global pricing, price cuts

Australia’s pharmaceutical industry is urging the country’s legislators to pass a new medicines pricing bill that aims to save Aus$1.9 …
News
Abbott Park

Abbott’s Meridia ‘increases heart attack risk’

September 2, 2010 Sales and Marketing Abbott, Meridia, drug safety

Abbott’s weight-loss drug Meridia increases the risk of stroke and heart attack in patients with heart disease, according a study …
News

Genzyme available for ‘fair value’, says Termeer

September 2, 2010 Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …
News

Cephalon chairman takes leave of absence

September 2, 2010 Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect. The company …
Appointment
Pandemrix pack

EMA to assess GSK flu vaccine for narcolepsy link

September 1, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …
News

Pharma and the iPhone: there’s an app for that

September 1, 2010 Medical Communications, Research and Development, Sales and Marketing ipad, iphone

The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …
Feature
Roche building

Roche coy on job cut reports

September 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
News

Paul Phull joins PharmaVentures

August 31, 2010 Sales and Marketing PharmaVentures, appointment, sales and marketing

Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business. He joins the company …
Appointment
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026